Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

81.66

+3.15 (4.01%)

At close: Oct 31, 2025, 4:00 PM EDT

83.33

+1.67 (2.05%)

After-hours: Oct 31, 2025, 6:56 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biologic Therapeutics	1.80M	Log In
Biologic Therapeutics Growth	-17.88%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.